Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes
- 31 May 2009
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 144 (1), 44-47
- https://doi.org/10.1016/j.ejogrb.2009.02.006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preoperative Treatment of Uterine Leiomyomas: Clinical Findings and Expression of Transforming Growth Factor-β3 and Connective Tissue Growth FactorReproductive Sciences, 2006
- Expression of Proliferating Cell Nuclear Antigen and Bcl-2 During a Pseudomenopausal State Induced by Presurgical Treatment of Uterine Leiomyomas With Gonadotropin-Releasing Hormone Analogues Plus TiboloneInternational Journal of Gynecological Pathology, 2005
- Clinical Response, Vascular Change, and Angiogenesis in Gonadotropin-Releasing Hormone Analogue-Treated Women with Uterine MyomasJournal of the Society for Gynecologic Investigation, 2005
- Effects of Gonadotropin-releasing Hormone Agonists on Uterine Volume and Vasculature and on the Immunohistochemical Expression of Basic Fibroblast Growth Factor (bFGF) in Uterine LeiomyomasInternational Journal of Gynecological Pathology, 2003
- Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trialFertility and Sterility, 2003
- Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopyHuman Reproduction, 2003
- Laparoscopic myomectomy: predicting the risk of conversion to an open procedureHuman Reproduction, 2001
- Uterine fibroidsThe Lancet, 2001
- Abdominal myomectomy: results of a simple operative techniqueFertility and Sterility, 1996
- Gonadotropin-Releasing Hormone Analog Treatment Should not Precede Conservative MyomectomyFertility and Sterility, 1990